Maya Kriseman1, Charity Mills2, Ertug Kovanci2, Haleh Sangi-Haghpeykar2, William Gibbons2. 1. Reproductive Endocrinology and Infertility, Baylor College of Medicine, 6651 Main St, Houston, TX, 77030, USA. mlkrisem@bcm.edu. 2. Reproductive Endocrinology and Infertility, Baylor College of Medicine, 6651 Main St, Houston, TX, 77030, USA.
Abstract
PURPOSE: The purpose of this paper is to determine whether antimullerian hormone (AMH) levels were associated with BMI in patients with diagnosed infertility, and more specifically, in patients with polycystic ovarian syndrome (PCOS). METHODS: A retrospective cohort study reviewed all females who presented to the clinical investigators' practice between November 2011 and March 2013. The following data was retrieved from the medical record: (1) AMH level, (2) age, (3) BMI, (4) ethnicity, and (5) if infertile, etiology of infertility. RESULTS: AMH levels were available for 489 women. Of these, 104 were diagnosed with PCOS. Overall, there was no association between BMI and AMH (r -0.04, p > 0.05). On the other hand, in the women with PCOS, there was a significant association between BMI and AMH (r -0.31, p < 0.01). CONCLUSIONS: BMI was not associated with AMH levels in the general population of infertile women or in patients without PCOS. However, BMI appeared to be significantly and inversely correlated with AMH in women with PCOS.
PURPOSE: The purpose of this paper is to determine whether antimullerian hormone (AMH) levels were associated with BMI in patients with diagnosed infertility, and more specifically, in patients with polycystic ovarian syndrome (PCOS). METHODS: A retrospective cohort study reviewed all females who presented to the clinical investigators' practice between November 2011 and March 2013. The following data was retrieved from the medical record: (1) AMH level, (2) age, (3) BMI, (4) ethnicity, and (5) if infertile, etiology of infertility. RESULTS:AMH levels were available for 489 women. Of these, 104 were diagnosed with PCOS. Overall, there was no association between BMI and AMH (r -0.04, p > 0.05). On the other hand, in the women with PCOS, there was a significant association between BMI and AMH (r -0.31, p < 0.01). CONCLUSIONS: BMI was not associated with AMH levels in the general population of infertilewomen or in patients without PCOS. However, BMI appeared to be significantly and inversely correlated with AMH in women with PCOS.
Entities:
Keywords:
Antimullerian hormone; Body mass index; Polycystic ovarian syndrome
Authors: Wendy A March; Vivienne M Moore; Kristyn J Willson; David I W Phillips; Robert J Norman; Michael J Davies Journal: Hum Reprod Date: 2009-11-12 Impact factor: 6.918
Authors: Seungyoun Jung; Naomi Allen; Alan A Arslan; Laura Baglietto; Louise A Brinton; Brian L Egleston; Roni Falk; Renée T Fortner; Kathy J Helzlsouer; Annika Idahl; Rudolph Kaaks; Eva Lundin; Melissa Merritt; Charlotte Onland-Moret; Sabina Rinaldi; María-José Sánchez; Sabina Sieri; Helena Schock; Xiao-Ou Shu; Patrick M Sluss; Paul N Staats; Ruth C Travis; Anne Tjønneland; Antonia Trichopoulou; Shelley Tworoger; Kala Visvanathan; Vittorio Krogh; Elisabete Weiderpass; Anne Zeleniuch-Jacquotte; Wei Zheng; Joanne F Dorgan Journal: Fertil Steril Date: 2017-04 Impact factor: 7.329
Authors: A Bothou; N Koutlaki; G Iatrakis; G Mastorakos; P Tsikouras; V Liberis; G Galazios; A Liberis; A Lykeridou; S Zervoudis Journal: Acta Endocrinol (Buchar) Date: 2017 Apr-Jun Impact factor: 0.877
Authors: Katrina M Volk; Veronika V Pogrebna; Jackson A Roberts; Jennifer E Zachry; Sarah N Blythe; Natalia Toporikova Journal: J Endocr Soc Date: 2017-11-02
Authors: Neil R Chappell; Beth Zhou; Amy K Schutt; William E Gibbons; Chellakkan S Blesson Journal: Endocr Connect Date: 2020-02-01 Impact factor: 3.335
Authors: Eleni Greenwood Jaswa; Julie S Rios; Marcelle I Cedars; Nanette F Santoro; Mary Ellen G Pavone; Richard S Legro; Heather G Huddleston Journal: J Clin Endocrinol Metab Date: 2020-10-01 Impact factor: 5.958